Working… Menu
Trial record 1 of 1 for:    NCT04115293
Previous Study | Return to List | Next Study

Safety, Tolerability, and Efficacy of Zilucoplan in Subjects With Generalized Myasthenia Gravis (RAISE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04115293
Recruitment Status : Active, not recruiting
First Posted : October 4, 2019
Last Update Posted : November 9, 2021
Information provided by (Responsible Party):
Ra Pharmaceuticals

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : February 2022